R&D Tax Credit Advance UK
In short: An R&D tax credit advance is a loan secured against your expected R&D tax relief. Rather than wait months for HMRC to process the claim, a specialist lender advances a share of it now, commonly around 70% to 80% of the expected benefit, and is repaid when HMRC pays. It suits R&D-intensive companies that want to extend runway between claims. The lender sizes and prices each advance on the claim and the company.
An R&D tax credit advance turns a claim you have not yet been paid into cash you can use now. Innovative UK companies build up a meaningful R&D tax benefit over a financial year, but HMRC can take months to process and pay it, and that gap often lands exactly when the company most needs the money. An advance closes the gap: a specialist lender advances a percentage of the expected credit and is repaid directly when HMRC settles the claim.
Lenders will advance against a claim in two ways. A retrospective advance is secured against a claim for a financial year that has ended, where the figure is reasonably settled and the risk is mainly HMRC processing time. An in-year or prospective advance funds against the claim building up in the current year before it is even filed, which frees cash sooner but carries more uncertainty, so lenders advance a smaller share and want a track record of previous successful claims. Advance rates commonly sit around 70% to 80% of the expected benefit, higher for a clean retrospective claim and lower for an in-year one.
The underlying relief changed recently, and lenders price around it. For accounting periods beginning on or after 1 April 2024 the SME and RDEC schemes were replaced by a single merged R&D scheme, with enhanced support retained for loss-making R&D-intensive SMEs. What that means for an advance is that the size and reliability of your claim, and whether it is prepared by a credible adviser, matter as much as the headline number. Lenders lean heavily on the quality of the claim and the company's claim history.
This is working capital for innovation: extending runway between funding rounds, bringing forward hires or equipment, and smoothing the lumpy timing of the credit. It is not a substitute for the claim itself or for equity. We are a commercial finance broker, not a lender or a tax adviser, so we do not prepare claims, set rates or decide applications; what we do is match your claim and your company to the lenders who fund R&D advances and know your sector. Sector detail sits on our pages for technology, manufacturing, renewable energy and healthcare and medtech.
Key Benefits
- Turns an R&D tax benefit that is months from being paid into working capital now, closing the cash gap that often lands between funding rounds
- Advances commonly run around 70% to 80% of the expected credit for a settled retrospective claim, with in-year advances available at a lower share for companies with a claim track record
- The advance is repaid directly from the HMRC credit when it lands, so it is self-liquidating against a benefit you were already due
- We match the claim to lenders who understand R&D relief and your sector, rather than a generalist lender treating the claim as an unknown
Frequently Asked Questions
How much of my R&D claim can I borrow against?
Commonly around 70% to 80% of the expected benefit for a settled, retrospective claim, where the main uncertainty is HMRC processing time. An in-year advance against a claim still building up in the current year is usually a smaller share, because the final figure is not yet fixed, and lenders will want to see a history of successful claims. The exact advance rate is the lender's decision once it has seen the claim and your accounts.
Can I get an advance before I have filed the claim?
Yes, with the right lender. An in-year or prospective advance funds against the R&D expenditure accruing in the current year before the claim is filed. It frees cash earlier but carries more uncertainty, so the advance rate is lower and lenders lean on your previous claims and the credibility of your R&D adviser. A retrospective advance against a completed year is simpler and usually funds a higher share.
How is the advance repaid?
It is repaid when HMRC pays the R&D credit, usually direct to the lender, which makes the facility self-liquidating against a benefit you were already due. If the claim is reduced or delayed by HMRC, the terms of your agreement govern what happens, so it matters that the claim is prepared properly and the figure is realistic. We can point you to lenders whose terms are fair on that point.
Does the merged R&D scheme change whether I can get an advance?
The underlying relief changed for accounting periods beginning on or after 1 April 2024, when the SME and RDEC schemes were merged into a single scheme, with enhanced support kept for loss-making R&D-intensive SMEs. It does not stop you raising an advance; it means the size and reliability of your claim under the current rules, and the quality of your claim preparation, drive what a lender will advance. We are not tax advisers, so take your claim adviser's view on the relief itself.
Related Funding Options
R&D Tax Credit Advance for Tech Companies
UK SaaS and tech companies can draw 80-90% of an R&D tax credit claim weeks after filing instead of waiting six to twelve months for HMRC. We place R&D advances with lenders who assess the claim itself as security.
R&D Tax Credit Advance for Manufacturers
If your manufacturing business is developing new products or improving processes, you likely have an R&D tax credit sitting with HMRC. As a commercial finance broker, CoreFi introduces you to lenders who advance that credit now, before HMRC pays out. No equity, no asset charge.
R&D Tax Credit Advance for Renewable Energy
UK clean energy & cleantech companies can draw against their R&D tax credit claim months before HMRC pays. We place these deals with lenders who understand technical R&D in renewable energy.
R&D Tax Credit Advance for Healthcare & Medtech Companies
Draw down your HMRC R&D tax credit cash now instead of waiting out the repayment cycle. We place R&D advances for UK medtech, biotech, pharmaceutical, and digital health companies from £25k to £2M.
Researching R&D Tax Credit Advance? Get the free guide
Plain-English, UK-specific. What it costs, who qualifies, and how to get the best terms, straight to your inbox.
- How r&d tax credit advance works and what it really costs
- Eligibility and the documents lenders ask for
- How CoreFi matches you to the right lenders from our panel
Ready to Get Funded?
Submit your details and we'll match you with the right lenders from our panel. No obligation, no fees.
Get matched with lendersCoreFi is a trading name of JG Core Ltd (Company #16218779, England & Wales). CoreFi acts as a commercial finance broker and does not provide regulated financial advice. All products described are unregulated business-to-business finance. Information on this page is for general guidance only and does not constitute a formal offer of finance. Terms, rates, and availability are subject to lender criteria and may change without notice.